CGRB posts

Feed

Analyst initiations: Cougar Biotech, Penford, AtriaCure

MOST NOTEWORTHY: Cougar Biotech, Penford and AtriaCure were today's noteworthy initiations:
  • Oppenheimer believes Cougar Biotech's (NASDAQ: CGRB) lead compound abiraterone is well positioned to address two underserved lines of therapy in prostate cancer with highly unmet medical needs. The firm assumed coverage of Cougar with a Buy rating and $43 target.
  • Jefferies believes Penford's (NASDAQ: PENX) initiatives to improve product mix and increase returns on capital should lift the company's valuation multiples, starting shares with a Buy rating and $33 target.
  • AtriaCure (NASDAQ: ATRC) was initiated with an Outperform rating and $17 target at Barrington, as they have confidence the company's minimally invasive approach will be the standard of care procedure for the less invasive surgical management of atrial fibrillation.
OTHER INITIATIONS:

Analyst initiations: ETN, EXPE, INTU, PCLN and SOHU

MOST NOTEWORTHY: The machinery industry, Sohu.com (SOHU), Intuit (INTU), Priceline.com (PCLN) and Expedia (EXPE) were today's noteworthy initiations:
  • Pali initiated Sohu.com (NASDAQ: SOHU) with a Buy rating and $41 target and believes the Olympic Games represent the biggest growth catalyst for the company.
  • Jefferies started shares of Intuit (NASDAQ: INTU) with a Buy rating and $34 target, likes the momentum in TurboTax and QuickBooks and sees potential upside fo FY08 expectations.
  • Banc of America initiated Priceline.com (NASDAQ: PCLN) with a Buy rating and $96 target and is positive on the company's European positioning given expectations for top line growth and margin expansion. The firm also started shares of Expedia (NASDAQ: EXPE) with a Buy rating and $35 target, positive on the company's strong management, solid competitive positioning and improving fundamentals.

OTHER INITIATIONS:
  • Omega Financial (NASDAQ: OMEF) was initiated at Keefe Bruyette with a Market Perform rating and $25 target.
  • Merrill Lynch initiated shares of Insulet (NASDAQ: PODD) with a Buy rating.
Analyst summaries provided by TheFlyOnTheWall.com (subscription required).

Symbol Lookup
IndexesChangePrice
DJIA+32.9612,834.19
NASDAQ+13.112,916.99
S&P 500+4.991,347.63

Last updated: February 13, 2012: 10:56 AM

Hot Stocks

General Electric

18.955+0.08(+0.42)

Alcoa

10.30+0.01(+0.10)

Apple Inc

499.08+5.66(+1.15)

Google Inc 'A'

611.22+5.31(+0.88)

Bank of America

8.225+0.155(+1.92)

Wal-Mart Stores

61.91+0.01(+0.02)

Exxon Mobil Corp

83.955+0.155(+0.18)

Ford

12.53+0.09(+0.72)

Citigroup

33.40+0.475(+1.44)

IBM

192.07-0.35(-0.18)

Yahoo

16.085-0.055(-0.34)

Starbucks

49.02+0.20(+0.41)

Microsoft

30.48-0.015(-0.05)

Home Depot

45.66+0.33(+0.73)

DailyFinance Headlines

AOL Business News

BioHealth Investor Headlines

Sponsored Links

My Portfolios

Track your stocks here!

Find out why more people track their portfolios on AOL Money & Finance then anywhere else.

BloggingStocks Partners

More from AOL Money & Finance

Page Loaded in 1329148573833 ms.